Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Regulatory

    Special Controls

    In one line
    Device-type-specific FDA requirements (often performance standards, labeling, or post-market surveillance) that apply on top of General Controls.
    Definition
    Special Controls are mandatory for Class II devices and are usually documented in a device-specific classification regulation or Special Controls guidance. They commonly require specific bench testing, biocompatibility, software documentation levels, or labeling statements. Special controls can include performance standards, mandatory testing, specific labeling, postmarket surveillance, patient registries or FDA guidance documents. They are written into the device's classification regulation, often when a De Novo is granted. A 510(k) for a device in that classification must show how each special control is met, typically in a dedicated section of the submission.
    Why it matters
    Mapping a 510(k) to its product code's Special Controls early prevents late-stage scope surprises and forms the basis of the testing plan.
    Common pitfalls
    • •Failing to identify all applicable Special Controls early in the device development process can lead to significant delays and redesigns.
    • •Misinterpreting the scope or requirements of a Special Control can result in non-compliant submissions and regulatory hurdles.
    • •Assuming that General Controls alone are sufficient for a Class II device, neglecting the additional requirements imposed by Special Controls, is a common error.
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.